June 13, 2024
Social

Tokyo, Japan (June 13, 2024) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Shoji Hirashima), has awarded its 17th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.


Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation, and innovative research projects with expectations for future development are eligible for the award.


The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 12, 2024.

*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research and overseas studies for Japanese researchers.

Recipients of the 17th Japan Research Foundation for Clinical Pharmacology Research Award

Recipient

Organization

Research theme

Kentaro Ushijima

Division of Pharmaceutics, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University

Methylprednisolone chrono-therapy for prevention for acute rejection in pediatric patients with living-donor liver transplantation

Yasuto Kinose

Department of Obstetrics and Gynecology Graduate School of Medicine, Osaka University

Establishment of precision medicine platform for rare gynecologic mesonephric adenocarcinoma using the mouse model patient-derived xenograft

Hisamitsu Hayashi

 Laboratory of Molecular Pharmacokinetics Graduate School of Pharmaceutical Sciences Development of Hepatoprotective Drugs for Pediatric Intractable Liver Diseases

Ryosuke Matsukane

Department of Pharmacy
Kyushu University Hospital

 Prospective observational study of anamorelin for the treatment of cancer cachexia in advanced pancreatic patients

Kosuke Yoshida

Nagoya University Graduate School of Medicine

 Identification of novel therapeutic agents for uterine leiomyosarcoma through multiomics analyses
Back to index